BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22843548)

  • 1. Independent genetic control of early and late stages of chemically induced skin tumors in a cross of a Japanese wild-derived inbred mouse strain, MSM/Ms.
    Okumura K; Sato M; Saito M; Miura I; Wakana S; Mao JH; Miyasaka Y; Kominami R; Wakabayashi Y
    Carcinogenesis; 2012 Nov; 33(11):2260-8. PubMed ID: 22843548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New chemically induced skin tumour susceptibility loci identified in a mouse backcross between FVB and dominant resistant PWK.
    Fujiwara K; Igarashi J; Irahara N; Kimura M; Nagase H
    BMC Genet; 2007 Jun; 8():39. PubMed ID: 17598916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis.
    Wang XJ; Greenhalgh DA; Jiang A; He D; Zhong L; Medina D; Brinkley BR; Roop DR
    Oncogene; 1998 Jul; 17(1):35-45. PubMed ID: 9671312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
    Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
    Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
    Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice.
    Chandramouli A; Shi J; Feng Y; Holubec H; Shanas RM; Bhattacharyya AK; Zheng W; Nelson MA
    Carcinogenesis; 2007 Sep; 28(9):2028-35. PubMed ID: 17389615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel genetic loci contributing to 12-O-tetradecanoylphorbol-13-acetate skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.
    Angel JM; Caballero M; DiGiovanni J
    Cancer Res; 2003 Jun; 63(11):2747-51. PubMed ID: 12782578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
    Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
    Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase.
    Lu YP; Lou YR; Yen P; Newmark HL; Mirochnitchenko OI; Inouye M; Huang MT
    Cancer Res; 1997 Apr; 57(8):1468-74. PubMed ID: 9108447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
    Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
    Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis.
    Weinberg WC; Fernandez-Salas E; Morgan DL; Shalizi A; Mirosh E; Stanulis E; Deng C; Hennings H; Yuspa SH
    Cancer Res; 1999 May; 59(9):2050-4. PubMed ID: 10232585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
    Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
    Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
    Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice.
    Suzuki JS; Nishimura N; Zhang B; Nakatsuru Y; Kobayashi S; Satoh M; Tohyama C
    Carcinogenesis; 2003 Jun; 24(6):1123-32. PubMed ID: 12807749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte.
    Woodworth CD; Michael E; Smith L; Vijayachandra K; Glick A; Hennings H; Yuspa SH
    Carcinogenesis; 2004 Sep; 25(9):1771-8. PubMed ID: 15105299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analyses of mouse skin tumor progression susceptibility using SENCAR inbred derived strains.
    Stern MC; Benavides F; LaCava M; Conti CJ
    Mol Carcinog; 2002 Sep; 35(1):13-20. PubMed ID: 12203363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Stmm3 locus conferring resistance to late-stage chemically induced skin papillomas on mouse chromosome 4 by congenic mapping and allele-specific alteration analysis.
    Saito M; Okumura K; Miura I; Wakana S; Kominami R; Wakabayashi Y
    Exp Anim; 2014; 63(3):339-48. PubMed ID: 25077764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
    Reiners JJ; Singh KP
    Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Polymorphic Variant in p19
    Saito M; Okumura K; Isogai E; Araki K; Tanikawa C; Matsuda K; Kamijo T; Kominami R; Wakabayashi Y
    J Invest Dermatol; 2019 Jul; 139(7):1459-1469. PubMed ID: 30684556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.